logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
G

Gerd R Burmester

department of rheumatology and clinical immunology

116H-index
962Paper Count
6.4WCitation Count
Published Papers 244
Publication Date
logo
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies
errRheumatology and Therapy
IF2.9
err2026-07-31
err0
errOAAI
errGerd R. Burmester; James Galloway; Karen Bevers; Jérôme Avouac; Susana Romero-Yuste; Roberto F. Caporali; Neil Betteridge; Carole Van der Donckt; Thomas P. A. Debray; Ouafia Tandjaoui Bouzid; Patrick Verschueren
errShare
errSave
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)
errRheumatology and Therapy
IF2.9
err2026-01-12
err0
errOAAI
errGeorg Pongratz; Rieke Alten; Torsten Witte; Christine Pausch; Robert Reinhold; David Pittrow; Gerd R. Burmester
errShare
errSave
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
errRheumatology and Therapy
IF2.9
err2025-11-20
err0
errOAAI
errRieke Alten; Gerd R. Burmester; Marco Matucci-Cerinic; Jean-Hugues Salmon; Andrew Östör; Khai Jing Ng; Jens Gerwien; Liliana Zaremba-Pechmann; Alan J. M. Brnabic; Bruno Fautrel
errShare
errSave
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
errAdvances in Therapy
IF4
err2025-08-28
err0
errOAAI
errGerd R. Burmester; Atul Deodhar; Alan D. Irvine; Remo Panaccione; Kevin L. Winthrop; Ruth Ann Vleugels; Gweneth Levy; Smitha Suravaram; Hannah Palac; Lani Wegrzyn; Sharanya Ford; Sebastian Meerwein; Emma Guttman-Yassky
errShare
errSave
Associations between childhood trauma; depression; anxiety disorders and early arthritis presence
errFrontiers in Medicine
IF3
err2025-08-07
err0
errOAAI
errAna Konjikusic; Sarah Ohrndorf; Tanja Braun; Vivien Kluckow; Vera Höhne-Zimmer; Gabriela Schmittat; Christine Heim; Ralf Uebelhack; Kirsten Minden; Jacqueline Detert; Gerd-Rüdiger Burmester; Desiree Schaumburg
errShare
errSave
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis
errClinical Drug Investigation
IF2.7
err2025-07-12
err0
errOAAI
errGerd Burmester; Jakub Trefler; Artur Racewicz; Janusz Jaworski; Agnieszka Zielińska; Marek Krogulec; Sławomir Jeka; Rafał Wojciechowski; Katarzyna Kolossa; Anna Dudek; Magdalena Krajewska-Włodarczyk; Paweł Hrycaj; Piotr Adrian Klimiuk; SungHyun Kim; JeeHye Suh; GoEun Yang; YunAh Kim; YooBin Jung; GaHee Park; Josef S. Smolen
errShare
errSave
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study
errlancet rheumatology
IF0
err2025-06-23
err0
errOAAI
errAndreas Hess; Koray Tascilar; Hanna M Schenker; Laura Konerth; Verena Schönau; Marina Sergeeva; Silke Kreitz; Jutta Prade; Sandra Strobelt; Mageshwar Selvakumar; Arnd Kleyer; Matthias Englbrecht; Axel J Hueber; Mario M Zaiss; Eugen Feist; Gerd R Burmester; Reinhard E Voll; Stephanie Finzel; Christoph Baerwald; Julie Rösch; Frank Behrens; Michaela Koehm; Jose Antonio P da Silva; Nemanja Damjanov; Arnd Dörfler; Georg Schett; Jürgen Rech
errShare
errSave
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study
errEXPERT REVIEW OF CLINICAL IMMUNOLOGY
IF3.7
err2025-01-15
err0
PREAI
errBurmester, Gerd; Klimiuk, Piotr Adrian; Trefler, Jakub; Jaworski, Janusz; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Lee, Hyunseung; Jang, Jiyoung; Hwang, Chankyoung; Lee, Hojae; Smolen, Josef S.
errShare
errSave
Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies (vol 44, pg 1233, 2024)
errRHEUMATOLOGY INTERNATIONAL
IF2.9
err2024-10-14
err0
errOAAI
errKadam, Esha; Javaid, Mahnoor; Sen, Parikshit; Saha, Sreoshy; Ziade, Nelly; Day, Jessica; Wincup, Chris; Andreoli, Laura; Parodis, Ioannis; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki; Dey, Dzifa; Cavagna, Lorenzo; Chatterjee, Tulika; Knitza, Johannes; Wang, Guochun; Dalbeth, Nicola; Velikova, Tsvetelina; Battista, Simone; Cheng, Karen; Boyd, Peter; Kobert, Linda; Gracia-Ramos, Abraham Edgar; Mittal, Srijan; Makol, Ashima; Gutierrez, Carlos Enrique Toro; Caballero-Uribe, Carlo V.; Kuwana, Masataka; Burmester, Gerd-Ruediger; Guillemin, Francis; Nikiphorou, Elena; Chinoy, Hector; Makhloufi, Chafia Dahou; Agarwal, Vikas; Gupta, Latika
errShare
errSave
Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination
errJOURNAL OF MEDICAL VIROLOGY
IF4.6
err2024-07-05
err0
errOAAI
errMei, Henrik E.; Schulz, Axel Ronald; Hirseland, Heike; Diekmann, Lisa-Marie; Habermann, Elisa; ten Hagen, Alexander; Albach, Fredrik; Burmester, Gerd-Ruediger; Gruetzkau, Andreas; Biesen, Robert
errShare
errSave
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open-label, single-dose phase I study
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2024-06-21
err1
errOAAI
errYu, Kyung-Sang; Ryu, Hyunwook; Shin, Dongseong; Park, Minkyu; Hwang, Jungi; Moon, Seol Ju; Kim, Min-Gul; Keystone, Edward; Smolen, Josef S.; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jang, Jiyoung; Yang, Goeun; Bae, Jihun; Lee, Jaeyong; Burmester, Gerd R.
errShare
errSave
CHARACTERIZATION OF PRECLINICAL RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS BY CLINICAL AND IMAGING PARAMETERS AND THEIR POTENTIAL ROLE IN THE PREDICTION OF ARTHRITIS
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errNendel, N.; Klotsche, J.; Schmittat, G.; Backhaus, M.; Kroenke, G.; Burmester, G. R.; Kokolakis, G.; Ohrndorf, S.
errShare
errSave
TO OPTIMIZE THE DIAGNOSTIC PROCESS OF RHEUMATIC DISEASES AFFECTING THE HANDS USING FOI
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errStumper, N.; Berger, J.; Gedat, E.; Hoff, P.; Schmittat, G.; Burmester, G. R.; Kroenke, G.; Backhaus, M.; Haugen, I. K.; Ohrndorf, S.
errShare
errSave
PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)TREATED WITH FILGOTINIB FOR UPTO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errAvouac, J.; Burmester, G. R.; Caporali, R. F.; Debray, T. P. A.; De Leonardis, F.; Galloway, J.; Betteridge, N.; Bevers, K.; Romero-Yuste, S.; Zignani, M.; Verschueren, P.
errShare
errSave
PHARMACOKINETICS, USABILITY AND SAFETY OF TOCILIZUMAB BIOSIMILAR (CT-P47) ADMINISTERED SUBCUTANEOUSLY BY AUTO-INJECTOR OR PRE- FILLED SYRINGE
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errKeystone, E.; Burmester, G. R.; Smolen, J. S.; Yu, K. S.; Ryu, H.; Shin, D.; Park, M.; Hwang, J.; Moon, S. J.; Kim, M.; Klimiuk, P. A.; Trefler, J.; Jaworski, J.; Kim, S. H.; Bae, Y.; Jeon, D.; Lee, H.; Jang, J.; Bae, J.
errShare
errSave
SAFETY OF UPADACITINIB ACROSS RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS ENCOMPASSING 15,000 PATIENT-YEARS OF CLINICAL TRIAL DATA
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errBurmester, G. R.; Cohen, S. B.; Deodhar, A.; Mysler, E.; Rubbert-Roth, A.; Tanaka, Y.; Winthrop, K. L.; Nakasato, P.; Coombs, D.; Gara, A.; Khan, N.; Kovacs, B.; Meerwein, S.; Curtis, J. R.
errShare
errSave
SIMILAR EFFICACY, SAFETY, AND IMMUNOGENICITY OFTOCILIZUMAB BIOSIMILAR (CT-P47) AND REFERENCE TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: WEEK 32 RESULTS FROM THE PHASE III SINGLE TRANSITION STUDY
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errSmolen, J. S.; Trefler, J.; Racewicz, A.; Jaworski, J.; Zielinska, A.; Krogulec, M.; Jeka, S.; Wojciechowski, R.; Kolossa, K.; Dudek, A.; Krajewska-Wlodarczyk, M.; Hrycaj, P.; Klimiuk, P. A.; Burmester, G. R.; Kim, S. H.; Bae, Y.; Jeon, D.; Yang, G.; Jung, Y.; Hong, J.; Keystone, E.
errShare
errSave
PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSEDTOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH INTRAVENOUS EU-APPROVEDTOCILIZUMAB AND US-LICENSEDTOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND,THREE-ARM, SINGLE-DOSE STUDY IN HEALTHY JAPANESE SUBJECTS
errANNALS OF THE RHEUMATIC DISEASES
IF20.6
err2024-06-01
err0
PREAI
errHaranaka, M.; Eto, T.; Tanaka, T.; Yazawa, R.; Burmester, G. R.; Keystone, E.; Kim, S. H.; Bae, Y.; Suh, J.; Kim, Y.; Lee, J.; Smolen, J. S.
errShare
errSave
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
errJOURNAL OF RHEUMATOLOGY
IF3.4
err2024-04-15
err2
PREAI
errBurmester, Gerd R.; van den Bosch, Filip; Tesser, John; Shmagel, Anna; Liu, Yanxi; Khan, Nasser; Camp, Heidi S.; Kivitz, Alan
errShare
errSave
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
errRHEUMATOLOGY INTERNATIONAL
IF2.9
err2024-04-12
err1
errOAAI
errKadam, Esha; Javaid, Mahnoor; Sen, Parikshit; Saha, Sreoshy; Ziade, Nelly; Day, Jessica; Wincup, Chris; Andreoli, Laura; Parodis, Ioannis; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki; Dey, Dzifa; Cavagna, Lorenzo; Chatterjee, Tulika; Knitza, Johannes; Wang, Guochun; Dalbeth, Nicola; Velikova, Tsvetelina; Battista, Simone; Cheng, Karen; Boyd, Peter; Kobert, Linda; Gracia-Ramos, Abraham Edgar; Mittal, Srijan; Makol, Ashima; Gutierrez, Carlos Enrique Toro; Uribe, Carlo V. Caballero; Kuwana, Masataka; Burmester, Gerd-Ruediger; Guillemin, Francis; Nikiphorou, Elena; Chinoy, Hector; Aggarwal, Vikas; Gupta, Latika
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
N
Naveed Sattar
H-index: 204 · Papers: 2.2K
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
P
Paul Emery
H-index: 158 · Papers: 1.6K
D
Désirée van der Heijde
H-index: 158 · Papers: 1.3K
G
Georg Schett
H-index: 154 · Papers: 1.7K
View more